Go back

‘Radical readjustment’ of clinical trials seeks to slash costs

Initiative supported by NHS and industry aims to make trials simpler for patients and researchers

A UK-based initiative has been launched to slash the costs of clinical trials by making it far simpler for patients and researchers to take part.

Protas, a not-for-profit organisation, has been set up to “radically readjust the economics” of late-stage clinical trials by designing studies from scratch to minimise their complexity and cost.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.